These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 14612552

  • 1. Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.
    Ott HW, Lindner H, Sarg B, Mueller-Holzner E, Abendstein B, Bergant A, Fessler S, Schwaerzler P, Zeimet A, Marth C, Illmensee K.
    Cancer Res; 2003 Nov 01; 63(21):7507-14. PubMed ID: 14612552
    [Abstract] [Full Text] [Related]

  • 2. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
    Chudecka-Głaz A, Rzepka-Górska I, Kosmowska B.
    Arch Gynecol Obstet; 2004 Nov 01; 270(3):151-6. PubMed ID: 12883823
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N, Oliva KT, Barker G, Hoffmann P, Reeve S, Smith IA, Quinn MA, Rice GE.
    Proteomics; 2005 Nov 01; 5(17):4625-36. PubMed ID: 16220531
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P, Frydecka I, Gabryś M, Van Dalen A, Einarsson R, Harłozińska A.
    Cancer; 2002 Nov 01; 95(9):1886-93. PubMed ID: 12404282
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
    Kim HJ, Kang HJ, Lee H, Lee ST, Yu MH, Kim H, Lee C.
    J Proteome Res; 2009 Mar 01; 8(3):1368-79. PubMed ID: 19186948
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG, Ruggiero M, Monteleone P, Carpi A, Cristello F, Cela V, Genazzani AR.
    Biomed Pharmacother; 2008 Mar 01; 62(6):373-7. PubMed ID: 18037256
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preoperative serum thrombopoietin levels are higher in patients with ovarian cancer than with benign cysts.
    Tsukishiro S, Suzumori N, Nishikawa H, Arakawa A, Suzumori K.
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep 01; 140(1):67-70. PubMed ID: 16359773
    [Abstract] [Full Text] [Related]

  • 20. Two-dimensional polyacrylamide gel electrophoresis map of bovine ovarian fluid proteins.
    Mortarino M, Vigo D, Maffeo G, Ronchi S.
    Electrophoresis; 1999 Sep 01; 20(4-5):866-9. PubMed ID: 10344260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.